News

Pfizer and BioNTech Update COVID-19 Vaccine Supply Agreement with EC

May 18, 2022

The companies have reached an agreement with the European Commission to update their COVID-19 vaccine supply agreement.

Avacta Establishes New Therapeutics Headquarters

May 16, 2022

Avacta is relocating its therapeutics headquarters to Scale Space in Imperial College’s White City Campus, London, United Kingdom.

Pfizer to Acquire Biohaven Pharmaceuticals for $11.7 Billion

May 16, 2022

Pfizer will acquire Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in migraine treatments, for $11.7 billion.

Avantor and Cytovance Biologics Partner on Plasmid DNA Development

May 13, 2022

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.

PCI Pharma Services Invests $100 Million in Bedford, NH Manufacturing Facility

May 12, 2022

PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.

Natoli Announces Tablet Press & Tooling Training Schedule at Company Headquarters

May 12, 2022

The “Tablet Press & Tooling: Applied Learning Experience” session will be held from June 14-16 at Natoli’s global headquarters in St. Charles, Mo.

FDA Launches Accelerated Rare Disease Cures Program

May 11, 2022

The agency’s Center for Drug Evaluation and Research has launched the new program to increase development of treatment options for patients with rare diseases.

FDA Publishes Draft Guidance on Quality Assessments

May 11, 2022

The draft guidance describes the benefit-risk principles used to conduct product quality-related assessments of CMC information submitted to FDA for assessment as part of NDAs, BLAs, or supplements.

FDA Approves Olumiant (baricitinib) to Treat COVID-19 in Hospitalized Adults

May 11, 2022

The drug is the first immunomodulatory COVID-19 treatment approved by FDA.

908 Devices and CPI Partner to Optimize Cell Culture Media for Improved Process Control

May 10, 2022

908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.